Physician
Leader, Joseph
Leader, Joseph was paid $30K by Medicaid between Jan 2020 and Mar 2023, across 10 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 64% of everything it billed.
33Billing provider infoLEADER, JOSEPH
WOBURN, MA 01801
WOBURN, MA 01801
33aNPI1457314940assigned 04/07/2006
33bProvider typePediatrics Physician
28Total paid$30K
24GClaims786
24DCodes billed10
24AFirst – last monthJan 2020 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#591 of 1,273
Median peer was paid$24K
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 284 | $6K | |
| 2021 | 277 | $13K | |
| 2022 | 213 | $11K | |
| 2023 | 12 | $51.12 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 64% | 292 | 287 | $19K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.9% | 40 | 39 | $3K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 8.2% | 17 | 17 | $2K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.5% | 70 | 70 | $2K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 4.4% | 134 | 134 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.5% | 12 | 12 | $765.24 |
| 99173 | 2.1% | 39 | 39 | $648.12 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.7% | 47 | 47 | $505.30 |
| 96127 | 1.6% | 111 | 110 | $472.86 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 24 | 12 | $233.88 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.